StonvexLoading…
StonvexStonvexStonvexCore line items from DHC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.54B | $1.50B | $1.41B | $1.28B |
Operating Income | $-320.90M | $-371.38M | $-272.67M | $-21.12M |
Net Income | $-285.89M | $-370.25M | $-293.57M | $-15.77M |
EPS (Diluted) | $-1.19 | $-1.55 | $-1.23 | $-0.07 |
Total Assets | $4.36B | $5.14B | $5.45B | $6.00B |
Total Liabilities | $2.70B | $3.18B | $3.11B | $3.36B |
Cash & Equivalents | $105.41M | $144.58M | $245.94M | $658.07M |
Free Cash Flow OCF − CapEx | $-166.44M | $-89.48M | $-224.52M | $-339.74M |
Shares Outstanding | 242.12M | 241.27M | 240.42M | 239.69M |